Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
02/2012
02/16/2012WO2012019966A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/16/2012US20120041207 Compound
02/16/2012US20120041194 Nitrogen and sulfur-containing hetrocycle derivatives
02/16/2012US20120041011 Substituted benzofused derivatives and their use as vanilloid receptor ligands
02/16/2012US20120040999 P38 kinase inhibiting agents
02/16/2012US20120040998 2-alkyl piperidine mglur5 receptor modulators
02/16/2012US20120040984 Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2012US20120040974 Mif modulators
02/16/2012US20120040972 Dual modulators of 5ht2a and d3 receptors
02/16/2012US20120040968 Diamino heterocyclic carboxamide compound
02/16/2012US20120040962 Fused ring inhibitors of hepatitis c
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012US20120040958 Indole carboxamides as ikk2 inhibitors
02/16/2012US20120040957 Novel Bicyclic Antibiotics
02/16/2012US20120040952 Azetidines as histamine h3 receptor antagonists
02/16/2012US20120040951 Heteroaryl compounds useful as raf kinase inhibitors
02/16/2012US20120040949 Inhibitors of Bruton's Tyrosine Kinase
02/16/2012US20120040937 Compounds for the treatment of proliferative disorders
02/16/2012US20120040933 9-(piperazinylalkyl) carbazoles as bax-modulators
02/16/2012US20120040826 Novel herbicides
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120039804 Novel Tricyclic Modulators of Cannabinoid Receptors
02/16/2012CA2808435A1 Heterocyclic compound
02/16/2012CA2807971A1 Heteroaryls and uses thereof
02/16/2012CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012CA2807880A1 Heteroarylpiperidine and -piperazine derivatives as fungicides
02/16/2012CA2807815A1 Synthesis for thiazolidinedione compounds
02/16/2012CA2805867A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
02/15/2012EP2418209A1 Aurora kinase modulators and method of use
02/15/2012EP2418207A1 Sulfone compounds which modulate the CB2 receptor
02/15/2012EP2418203A1 Cyclic compound having substituted phenyl group
02/15/2012EP2417123A2 Therapeutic compositions and related methods of use
02/15/2012EP2417122A1 Indole derivatives and methods for antiviral treatment
02/15/2012EP2417120A1 Substituted piperidines as ccr3 antagonists
02/15/2012EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
02/15/2012EP2417108A1 Organic compounds and their uses
02/15/2012EP2027107B1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
02/15/2012EP1771441B8 Novel carboxamides for use as xa inhibitors
02/15/2012CN102356081A Bicyclic compounds for the reduction of beta-amyloid production
02/15/2012CN102356080A Amorphous salt of macrocyclic inhibitor of hcv
02/15/2012CN102356075A Compositions and methods for inhibition of the jak pathway
02/15/2012CN102356065A Piperidine derivatives as nk3 receptor antagonists
02/15/2012CN102351855A Production method of beta-crystal form aztreonam aseptic raw drug
02/15/2012CN102351854A Amino thiazole derivative and preparation method and medical purpose thereof
02/15/2012CN102351791A Cyanoisoquinoline compounds capable of making hypoxia inducible factor (HIF) stable
02/14/2012US8114893 Compounds and methods of use
02/14/2012US8114867 Oxazolidinone antibiotic derivatives
02/14/2012CA2651653C 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/09/2012WO2012018059A1 Heterocyclic compound
02/09/2012WO2012017020A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
02/09/2012WO2012016970A1 A crystalline form of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4 -methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl)-amide and its use as pi3k inhibitor
02/09/2012US20120035360 Dual-color imaging method of sodium/calcium activities using two-photon fluorescent probes and preparation method of two-photon fluorescent probes
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035187 Anti-neurodegenerative disease agent
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035163 Novel fused ring compound and use thereof
02/09/2012US20120035162 Process for preparation of high-purity meloxicam and meloxicam potassium salt
02/09/2012US20120035161 Novel Compositions and Methods of Treating Diseases Using the Same
02/09/2012US20120035157 2-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/2012US20120035149 Prokineticin Receptor Antagonists And Uses Thereof
02/09/2012US20120035131 Pyrazoline compounds
02/09/2012US20120035051 Novel Heterocyclic Thiosubstituted Alkanol Derivatives
02/09/2012US20120034315 Solid forms of an azocyclic amide
02/09/2012CA2807511A1 Processes for preparing tubulysins
02/09/2012CA2806015A1 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein
02/08/2012EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors
02/08/2012EP2415765A1 Pyrimidine compound
02/08/2012EP2415764A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
02/08/2012EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma
02/08/2012EP2415759A1 CETP inhibitors
02/08/2012EP2414346A1 Autotaxin inhibitors
02/08/2012EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors
02/08/2012EP2414328A2 Dihydroorotate dehydrogenase inhibitors
02/08/2012EP2414325A2 Method of preparing an inhibitor of cytochrome p450 monooxygenase, and intermediates involved
02/08/2012EP2144898B1 Heterocyclic hydrazide compound and pesticidal use of the same
02/08/2012CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound
02/08/2012CN1930136B 异*唑啉取代苯甲酰胺化合物及有害生物防除剂 * Iso-oxazoline-substituted benzamide compound and the pest control agent
02/08/2012CN102348697A 磺酰胺衍生物 Sulfonamide derivatives
02/08/2012CN102344445A Optical voidness quinazoline compound
02/08/2012CN102344444A Optically pure quinazoline compounds
02/08/2012CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
02/08/2012CN101982468B 噁唑烷酮衍生物以及含有该衍生物的药物组合物 Oxazolidinone derivatives and pharmaceutical compositions containing the derivative
02/08/2012CN101891708B 一种含4-甲基-1,2,3-噻二唑基团的双酰肼类化合物及其制备方法和用途 Containing methyl-1,2,3-thiadiazole group diacylhydrazine compound and its preparation and use
02/08/2012CN101415687B 鞘氨醇-1-磷酸结合抑制物质 Sphingosine-1-phosphate binding-inhibiting substance
02/08/2012CN101410394B 抑制人免疫缺陷病毒的5-(羟基亚甲基和氨基亚甲基)取代的嘧啶 Inhibition of human immunodeficiency virus 5- (hydroxymethylene and aminomethylene) pyrimidine substituted
02/07/2012US8110686 Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
02/07/2012US8110683 Piperidinyl compounds that selectively bind integrins
02/07/2012US8110590 Synthesis of epothilones, intermediates thereto and analogues thereof
02/07/2012US8110574 Derivatives of 4-aminopiperidine and their use as a medicament
02/07/2012CA2663366C Compounds and compositions as protein kinase inhibitors
02/07/2012CA2471044C Benzimidazole derivatives and their use as gnrh antagonists
02/02/2012WO2012015693A1 Imidazole derivatives
02/02/2012WO2012015265A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/02/2012WO2012014955A1 Novel azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording and inkjet recording
02/02/2012WO2012014954A1 Novel azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording and inkjet recording
02/02/2012WO2012014149A1 N-methylformamide solvate of dasatinib
02/02/2012WO2012013728A1 Arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use
02/02/2012WO2012013643A1 Hetero-bicyclic derivatives as hcv inhibitors
02/02/2012WO2011151436A3 Azepin-derivatives as derivatives as g- protein coupled receptor (gpr43) agonists
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 628